Stocks TelegraphStocks Telegraph
Stock Ideas

ELTX Company Profile and Key Details

NASDAQ : ELTX

Elicio Therapeutics, Inc.

$6.87
0.42+6.51%
Open: 2:19 PM

ELTX Stock Price Chart

Stock Price Today

Elicio Therapeutics, Inc. (ELTX) stock surged +6.51%, trading at $6.87 on NASDAQ, up from the previous close of $6.45. The stock opened at $6.46, fluctuating between $6.40 and $6.87 in the recent session.

Stock Snapshot

6.45
Prev. Close
6.46
Open
74.14M
Market Cap
10.79M
Number of Shares
6.3955
Day Low
6.87
Day High
-1.94
P/E Ratio
75.33%
Free Float in %
-3.55
EPS (TTM)
N/A
Book Value
N/A
Cash Flow per Share
31.46K
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Jan 21, 20256.406.456.206.4522.02K
Jan 17, 20256.486.526.256.2512.05K
Jan 16, 20256.456.556.306.4416.97K
Jan 15, 20256.406.416.206.3918.9K
Jan 14, 20256.006.256.006.0727.93K
Jan 13, 20256.196.225.865.8627.66K
Jan 10, 20255.726.155.726.1333.74K
Jan 08, 20256.036.405.505.6788.3K
Jan 07, 20255.536.095.536.0331K
Jan 06, 20255.335.995.335.8034.4K
Jan 03, 20255.435.665.145.6248.3K
Jan 02, 20254.975.144.975.149.38K
Dec 31, 20244.935.104.875.109K
Dec 30, 20245.205.204.925.0028.85K
Dec 27, 20245.175.175.055.096.57K
Dec 26, 20245.325.325.065.079.35K
Dec 24, 20245.015.255.015.2411.42K
Dec 23, 20245.105.104.955.0314.44K
Dec 20, 20245.005.024.704.8825.35K
Dec 19, 20245.015.085.015.023.94K

Contact Details

Boston, MA 02210

United States

Website: https://elicio.comContact: 857 209 0050

About Company

Elicio Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases. The company's lead product candidate is ELI-002, an AMP therapeutic vaccine for the treatment of KRAS-driven cancers. It is also developing ELI-004, an AMP-modified CpG adjuvant, a component of ELI-002; ELI-007, a lymph node targeted AMP-peptide vaccine for mutant BRAF-driven cancers; ELI-008, a multivalent lymph node targeted AMP-peptide vaccine for mutant TP53-expressing cancers; ELI-005, a vaccine candidate for the prevention of COVID-19; ELI-011 for the treatment of hematological cancers; and ELI-012, a mKRAS TCR T cell AMP-lifier designs to use in combination with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company is headquartered in Boston, Massachusetts.

Company Information

Employees32
Beta0
Sales or RevenueN/A
5Y Sales Change%-1%
Fiscal Year EndsN/A
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current Elicio Therapeutics, Inc. (ELTX) stock price?

Elicio Therapeutics, Inc. (NASDAQ: ELTX) stock price is $6.87 in the last trading session. During the trading session, ELTX stock reached the peak price of $6.87 while $6.40 was the lowest point it dropped to. The percentage change in ELTX stock occurred in the recent session was 6.51% while the dollar amount for the price change in ELTX stock was $0.42.

ELTX's industry and sector of operation?

The NASDAQ listed ELTX is part of Biotechnology industry that operates in the broader Healthcare sector. Elicio Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ELTX?

No Data

How ELTX did perform over past 52-week?

ELTX's closing price is 117.91% higher than its 52-week low of $2.96 where as its distance from 52-week high of $11.45 is -43.67%.

How many employees does ELTX have?

Number of ELTX employees currently stands at 32.

Link for ELTX official website?

Official Website of ELTX is: https://elicio.com

How do I contact ELTX?

ELTX could be contacted at phone 857 209 0050 and can also be accessed through its website. ELTX operates from 451 D Street, Boston, MA 02210, United States.

How many shares of ELTX are traded daily?

ELTX stock volume for the day was 31.46K shares. The average number of ELTX shares traded daily for last 3 months was 26.6K.

What is the market cap of ELTX currently?

The market value of ELTX currently stands at $74.14M with its latest stock price at $6.87 and 10.79M of its shares outstanding.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph